Except they have grown all major metrics including revenue for a novel product in essentially one of the worst impacted industries over the last two years.
Total income grew by multiples prior to covid, and then they've even managed to maintain modest growth since then.
Considering other companies have seen their top-line numbers get wiped out, it seems fairly obtuse to not consider that meaningful.
Ann: Offer Booklet, page-13
Add PCK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $45.80M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | 2.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.8¢ | 86115 | 1 |
View Market Depth
| Last trade - 08.18am 31/05/2024 (20 minute delay) ? |
| PCK (ASX) Chart |
Day chart unavailable